Supplements to Lower Blood Sugar

An Integrative Approach to Lowering Blood Sugar

Printable Version 

Hundreds of dietary supplements including herbals, vitamins and minerals have been reported to have beneficial anti-glycemic effects for patients with diabetes though, in most cases, evidence is of poor quality. The best current evidence on supplements is presented below.

Note: Dietary supplements are intended to supplement the diet. They are not medicines and are not intended to treat, diagnose, mitigate, prevent, or cure disease. In some cases, dietary supplements may have unwanted effects, especially if taken before surgery or with other dietary supplements or medicines, or if you have certain health conditions. Also, supplements are not regulated with the same degree of oversight as medications. Products vary greatly in terms of accuracy of labels, presence of contaminants, and the validity of claims on the label. Work with your health care provider to determine how best to achieve optimal health.

Herbal Supplements

Many modern pharmaceuticals have natural plant origins. Among them, metformin was derived from Galega officinalis (goat’s rue or French lilac), a traditional remedy for diabetes used in Europe since the Middle Ages. Many botanicals are used for glycemic control and management of diabetic complications. Below are two examples of botanicals, cinnamon and Nigella sativa, that have more than one review/meta-analysis to support their efficacy in diabetes. Some botanical supplements have one recent review/meta-analysis supporting their role in diabetes. These include:

  • Milk thistle1
  • Purslane2
  • Ginseng-related therapies3
  • Nettle4

Other botanicals that have less robust evidence supporting their use in managing blood sugars include the following:

  • Bitter melon
  • Fenugreek
  • Gymnema
  • Pycnogenol
  • Prickly pear

Cinnamon

True cinnamon (Cinnamomum zeylanicum), Chinese cinnamon (Cinnamomum cassia) and Indonesian cinnamon (Cinnamomum burmanni) are among 300 species of Cinnamomum that belong to the Lauraceae family. Pooled results from a 2012 Cochrane Review showed no effect on HbA1c of these three types of cinnamon on patients with type 1 or type 2 diabetes mellitus.5

These results are in conflict with a 2011 meta-analysis demonstrating a significant improvement in fasting blood glucose (FBG) with whole and extract Cinnamon cassia.6 A 2019 review and meta-analysis of 18 studies showed that cinnamon did significantly reduce fasting blood sugar by an average of 19.26 mg/dL; however, there was no significant change in hemoglobin A1c, body weight, body mass index, or waist circumference. Due to the heterogeneity of the studies, the evidence is still inconclusive.7

Nigella Sativa (Fennel Flower, Black Seed, Black Cumin)

Nigella is a plant that belongs to the family Raninculaceae and has been used in medicine for centuries, especially in Southeast Asia and the Middle East. While the optimal dosage and formulation are yet to be determined, there have been three systematic reviews/meta-analyses that have provided encouraging evidence to support Nigella’s health benefits for people who have been diagnosed with diabetes. A 2016 review of 23 articles including 1,531 participants showed that fasting blood sugar (FBS) was reduced significantly in 13 studies.8 A 2017 review and meta-analysis suggested effectiveness in glucose homeostasis and improvement in serum lipids.9 Lastly, a 2019 review and meta-analysis concluded that Nigella significantly benefits glycemic status.10 If this were to be considered as part of a treatment plan, the Natural Medicines Food, Herbs, and Supplements Database suggests that black seed powder be dosed at 1 gm twice daily for 3-12 months, based on what has been used in the literature. Black seed oil 450mg three times daily for 12 weeks has also been used.11

Vitamins and Minerals

Although the ADA does not generally support the use of micronutrient supplements for people with diabetes, they recommend that people who are at increased risk for micronutrient deficiencies (e.g., those following very-low-calorie diets, the elderly, and strict vegetarians) may benefit from multivitamin supplements.

Magnesium

Magnesium deficiency is seen with decreased absorption (as in patients with poor diets high in processed food) or increased elimination (as in people who use alcohol, caffeine, or take diuretics or birth control pills). Dietary sources include whole grains, leafy green vegetables, legumes, and nuts. Magnesium is involved in insulin secretion, binding, and activity. Results of a 2006 meta-analysis support improvement in FBS but not HbA1c.12 A 2017 review and meta-analysis concluded that magnesium supplementation can lead to improved FBG, HDL, LDL, triglycerides, and systolic blood pressure in people diagnosed with diabetes, suggesting it may be beneficial in mitigating cardiovascular disease associated with diabetes.13

Alpha-lipoic acid (ALA)

Alpha-Lipoic Acid (ALA) is an antioxidant made by the body and also found in very small amounts in foods. ALA is widely used in Europe and shows promise in the treatment of diabetic neuropathy. Small studies show ALA may reduce oxidative stress and improve insulin sensitivity in patients with diabetes14 and a recent small randomized controlled trial (RCT) showed a statistically significant decrease in FBG and post-prandial glucose after eight weeks.15 A 2019 systematic review and meta-analysis of 31 trials demonstrated that ALA significantly improves hemoglobin A1c (decreased by 0.35% on average) FBS, in addition to other inflammatory biomarkers such including tumor necrosis factor alpha, interleukin 6, and C-reactive protein.16

Vitamin D

Individuals with the highest vitamin D status (>25 ng/ml) have a 43% lower risk of developing type 2 diabetes mellitus (T2DM) compared with those in the lowest group (<14 ng/ml).17 Recent studies have suggested that vitamin D supplementation may confer a positive effect on glycemic control. One 2017 review and meta-analysis of 29 trials including 3324 participants found a modest reduction in A1c (decreased by 0.32% on average)18. Another meta-analysis in 2018 suggested that vitamin D supplementation may reduce insulin resistance, especially in people who are vitamin D deficient and have well-controlled A1c at baseline.19 In addition, several reviews and meta-analyses have been published on the benefits vitamin D supplementation may have in improving lipid profile,20 diastolic blood pressure21, and chronic inflammation,22 though the results are still not conclusive.23 While there have been studies on very high dose vitamin D as a treatment for diabetes, data are not sufficient at this time to support this treatment approach.24

Zinc

Zinc has an interesting relationship with the body’s glucose metabolism. First, zinc plays a key role in the production and secretion of insulin. In addition, zinc is excreted in the urine when blood glucose levels are high, so people with diabetes often have lower zinc serum levels than those without diabetes.25 Therefore, to support the body’s natural insulin function, it can be helpful to consider zinc supplementation.26 That being said, a 2015 Cochrane review of three trials with a total of 128 participants concluded that as of that time there was no evidence on which to base the use of zinc in the prevention of type 2 diabetes.27 More recently, a 2017 systematic review of 15 original studies demonstrated a negative correlation between hemoglobin A1c percentage and plasma zinc levels, concluding that zinc supplementation in people with type 2 diabetes did, in fact, improve glycemic control.28 A recommended dose of zinc in people diagnosed with diabetes would be zinc gluconate 25mg twice daily.29

Folate

Higher levels of homocysteine have been associated with higher insulin resistance and risk of type 2 diabetes. As folate supplementation is one way of lowering homocysteine, it is thought to be a way to mitigate elevated blood glucose levels. A 2019 meta-analysis concluded that folate may be beneficial in supporting glucose homeostasis and lowering insulin resistance, decreasing A1c by 0.46% on average.30 A 2018 review and meta-analysis of 18 trials including 21,081 participants showed a decrease in fasting glucose by 0.15mmol/L but no significant effect on A1c.31 There is no standard dose of folate recommended for blood sugar management at this time; however, Natural Medicines Food, Herbs and Supplements Database lists 1mg of folic acid once daily as a dose that has been studied to support people with diabetic neuropathy.32

Omega-3 Polyunsaturated Fatty Acids (PUFAs)

There has been much attention given to the role PUFAs play in the prevention and treatment of diseases related to inflammation. Authors of a 2009 Cochrane Review found no significant change in HbA1c, fasting glucose, or fasting insulin although triglyceride (TG) and very low density lipid (VLDL) levels were significantly improved.33 There are no data supporting reduced risk of macrovascular outcomes or mortality from PUFA supplementation.33 Additionally, a recent meta-analysis of 18 separate cohorts (n= 540,184 individuals and 25,670 cases of incident T2DM) found no harms or benefits associated with fish/seafood or omega-3 (fatty acids EPA and DHA) supplementation on the development of T2DM.34 A 2015 meta-analysis of 20 RCTs found that omega-3 supplementation only significantly decreased triglyceride levels in participants diagnosed with Type 2 diabetes.35

Fiber Supplementation

The ADA recommends a goal of 25-35 gm of dietary fiber daily for a healthy diet. Dietary fiber supplementation has been shown to improve glucose control.36 Other review studies have shown that non-oil seed pulses, either alone or in combination with a high fiber diet, improve glycemic control in patients with T2DM, although significant inter-study heterogeneity exists.37 A 2015 meta-analysis showed that psyllium fiber showed the greatest improvement in glycemic control in people who were already being actively treated for T2DM, as opposed to people with prediabetes or those who were euglycemic.38

Probiotics

A 2016 systematic review and meta-analysis demonstrated that probiotics seem to have a beneficial role in managing type 2 diabetes, significantly decreasing fasting blood glucose and hemoglobin A1c.39 A 2015 meta-analysis showed an average reduction of A1c by 0.81% with probiotic supplementation.40 Another 2016 review and meta-analysis showed significant reduction of fasting blood glucose by 0.98 mmol/L (though it did not corroborate a significant decrease in A1c) with probiotic consumption.41 In addition, a 2017 meta-analysis demonstrated that probiotic supplementation in people with type 2 diabetes was associated with a significant improvement in both A1c and fasting insulin.42 One meta-analysis concluded that the beneficial effect of probiotics on glucose metabolism was greatest when the duration of supplementation was greater than or equal to 8 weeks and when multiple probiotic species were consumed.43 Another 2017 meta-analysis suggested that probiotics may also be an effective way to decrease cholesterol levels and blood pressure in addition to FBG.

Table 1. Evidence of Effects of Dietary Supplements on Glycemic Control in Patients with Type 2 Diabetes

Table 1: Evidence of Effects of Dietary Supplements and Glycemic Control in Patients with Type 2 Diabetes

Supplement and Study Design

Dose and How Long Supplement Taken

Findings

Cinnamon5

Meta-analysis

10 RCTs

577 participants

<1-3 g, average 2g daily for 4-16 weeks

No effect on HbA1c (-0.06%; 95% CI -0.29 to 0.18; P = 0.63; n = 405; 6 trials)

Borderline effect FBG (-0.83 mmol/L; 95% CI -1.67 to 0.02; P = 0.06; n = 388; 8 trials.)

Cinnamon6

Meta-analysis

8 RCTs

369 participants

250 mg-6 g daily for 4-16 weeks

Significant improvement in FBG (–0.49 – 0.2 mmol/L; P = .025; n=369; 8 trials)

Magnesium12

Meta-analysis

9 RCTs

370 participants

360 mg daily median dose for

4-16 weeks

Significant improvement FBG (−0.56 mmol/l; 95% CI 1.10 to −0.01)

Nonsignificant improvement in HbA1c (−0.31%; 95% CI −0.81 to 0.19)

Alpha-Lipoic Acid (ALA)15

RCT

57 participants

300 mg daily for 8 weeks

Significant improvement FBG (185mg/dl vs.156mg/dl; p<0.0001) and PPG (278mg/dl vs. 238mg/dl; p<0.023)

Vitamin D17

Systematic review

8 RCTs with no DM

3 trials with type 2 DM

400 IU-8600 IU daily for 6 weeks-7 years

No glycemic effect on patients with normal glucose tolerance at baseline

No effect on glycemic control in Type 2 DM

Omega-3 Fatty Acids/Fish Oil33

Meta-analysis

23 RCTs

1075 participants

Average of 3.5 g daily for a mean of 8.9 weeks

No significant change HbA1c, FBG, HDL

TG Decreased (-0.45 mmol/L; 95% CI -0.58 to -0.32, P < 0.00001)

VLDL Decreased -0.07 mmol/L (95% CI -0.13 to 0.00, P = 0.04)

LDL Increased+ 0.11 mmol/L (95% CI 0.00 to 0.22, P = 0.05)

Dietary Fiber Supplementation36

Meta-analysis

15 RCTs

4-40 gm fiber daily. Avg 15 gm daily, total soluble and insoluble fiber

Significant improvement in HbA1c (-0.26%; 95% CI 0.02 to – 0.51)

Significant improvement in FBG
(-85 mmol/L; 95% CI, 0.46 to
–1.25)

DM = Diabetes mellitus; FBG = Fasting blood glucose; HbA1c = Hemoglobin A1c

HDL = High Density Lipoprotein; IU = International Units; LDL = Low Density Lipoprotein

RCT = Randomized Controlled Trial; TG = Triglycerides; VLDL = Very Low Density Lipoprotein

Resource Links

What we know about integrative health care has come to us thanks to the efforts, experiences, and collective wisdom of people from many cultures and backgrounds. We wish to acknowledge all the healers, researchers, patients, and peoples who have informed the content of this tool.

Author(s)

This handout was adapted for the Osher Center for Integrative Health at the University of Wisconsin-Madison from the original by Jacqueline Redmer, MD, MPH and updated by Vincent Minichiello, MD.

Originally Created: 2014, Updated: 2020

Modified for UW Integrative Medicine: 2021

References

  1. Hadi A, Pourmasoumi M, Mohammadi H, Symonds M, Miraghajani M. The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Complement Ther Med. Dec 2018;41:311-319. doi:10.1016/j.ctim.2018.08.010
  2. Hadi A, Pourmasoumi M, Najafgholizadeh A, Kafeshani M, Sahebkar A. Effect of purslane on blood lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. Jan 2019;33(1):3-12. doi:10.1002/ptr.6203
  3. Gui QF, Xu ZR, Xu KY, Yang YM. The efficacy of ginseng-elated therapies in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Medicine (Baltimore). Feb 2016;95(6):e2584. doi:10.1097/md.0000000000002584
  4. Ziaei R, Foshati S, Hadi A, et al. The effect of nettle (Urtica dioica) supplementation on the glycemic control of patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Phytother Res. Feb 2020;34(2):282-294. doi:10.1002/ptr.6535
  5. Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 2012;9:Cd007170. doi:10.1002/14651858.CD007170.pub2
  6. Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. Sep 2011;14(9):884-9. doi:10.1089/jmf.2010.0180
  7. Namazi N, Khodamoradi K, Khamechi SP, Heshmati J, Ayati MH, Larijani B. The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials. Complement Ther Med. Apr 2019;43:92-101. doi:10.1016/j.ctim.2019.01.002
  8. Mohtashami A, Entezari MH. Effects of Nigella sativa supplementation on blood parameters and anthropometric indices in adults: A systematic review on clinical trials. J Res Med Sci. 2016;21:3. doi:10.4103/1735-1995.175154
  9. Daryabeygi-Khotbehsara R, Golzarand M, Ghaffari MP, Djafarian K. Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis. Complement Ther Med. Dec 2017;35:6-13. doi:10.1016/j.ctim.2017.08.016
  10. Askari G, Rouhani MH, Ghaedi E, Ghavami A, Nouri M, Mohammadi H. Effect of Nigella sativa (black seed) supplementation on glycemic control: A systematic review and meta-analysis of clinical trials. Phytother Res. May 2019;33(5):1341-1352. doi:10.1002/ptr.6337
  11. (TRC) TRC. Black Seed. March 11, 2020. Accessed April 30, 2020. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=901#dosing
  12. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. Oct 2006;23(10):1050-6. doi:10.1111/j.1464-5491.2006.01852.x
  13. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet. Oct 2017;30(5):621-633. doi:10.1111/jhn.12454
  14. Poh ZX, Goh KP. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets. Dec 2009;9(4):392-8.
  15. Ansar H, Mazloom Z, Kazemi F, Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Medical Journal. Jun 2011;32(6):584-8.
  16. Rahimlou M, Asadi M, Banaei Jahromi N, Mansoori A. Alpha-lipoic acid (ALA) supplementation effect on glycemic and inflammatory biomarkers: A Systematic Review and meta- analysis. Clin Nutr ESPEN. Aug 2019;32:16-28. doi:10.1016/j.clnesp.2019.03.015
  17. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. Sep 2011;65(9):1005-15. doi:10.1038/ejcn.2011.118
  18. Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complications. Jul 2017;31(7):1115-1126. doi:10.1016/j.jdiacomp.2017.04.019
  19. Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients. Mar 19 2018;10(3)doi:10.3390/nu10030375
  20. Jafari T, Fallah AA, Barani A. Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Clin Nutr. Dec 2016;35(6):1259-1268. doi:10.1016/j.clnu.2016.03.001
  21. Lee KJ, Lee YJ. Effects of vitamin D on blood pressure in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther. Apr 2016;54(4):233-42. doi:10.5414/cp202493
  22. Mousa A, Naderpoor N, Teede H, Scragg R, de Courten B. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. May 1 2018;76(5):380-394. doi:10.1093/nutrit/nux077
  23. Swart KM, Lips P, Brouwer IA, et al. Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. Jun 1 2018;107(6):1043-1053. doi:10.1093/ajcn/nqy078
  24. Lips P, Eekhoff M, van Schoor N, et al. Vitamin D and type 2 diabetes. J Steroid Biochem Mol Biol. Oct 2017;173:280-285. doi:10.1016/j.jsbmb.2016.11.021
  25. Fernández-Cao JC, Warthon-Medina M, Hall Moran V, Arija V, Doepking C, Lowe NM. Dietary zinc intake and whole blood zinc concentration in subjects with type 2 diabetes versus healthy subjects: A systematic review, meta-analysis and meta-regression. J Trace Elem Med Biol. Sep 2018;49:241-251. doi:10.1016/j.jtemb.2018.02.008
  26. Diabetes.co.uk. Vitamins and Minerals. Updated January 15, 2019. https://www.diabetes.co.uk/vitamins-supplements.html
  27. El Dib R, Gameiro OL, Ogata MS, et al. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane Database Syst Rev. May 28 2015;(5):Cd005525. doi:10.1002/14651858.CD005525.pub3
  28. de Carvalho GB, Brandão-Lima PN, Maia CS, Barbosa KB, Pires LV. Zinc's role in the glycemic control of patients with type 2 diabetes: a systematic review. Biometals. Apr 2017;30(2):151-162. doi:10.1007/s10534-017-9996-y
  29. Therapeutic Research Center (TRC). Zinc. Accessed July 23, 2020. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=982
  30. Lind MV, Lauritzen L, Kristensen M, Ross AB, Eriksen JN. Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials. Am J Clin Nutr. Jan 1 2019;109(1):29-42. doi:10.1093/ajcn/nqy234
  31. Zhao JV, Schooling CM, Zhao JX. The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Ann Epidemiol. Apr 2018;28(4):249-257.e1. doi:10.1016/j.annepidem.2018.02.001
  32. (TRC) TRC. Folic Acid. Accessed April 17, 2020. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=1017#dosing
  33. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008;(1):Cd003205. doi:10.1002/14651858.CD003205.pub2
  34. Wu JH, Micha R, Imamura F, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. Jun 2012;107 Suppl 2:S214-27. doi:10.1017/s0007114512001602
  35. Chen C, Yu X, Shao S. Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: a meta-analysis. PLoS One. 2015;10(10):e0139565. doi:10.1371/journal.pone.0139565
  36. Post RE, Mainous AG, 3rd, King DE, Simpson KN. Dietary fiber for the treatment of type 2 diabetes mellitus: a meta-analysis. J Am Board Fam Med. Jan-Feb 2012;25(1):16-23. doi:10.3122/jabfm.2012.01.110148
  37. Sievenpiper JL, Kendall CW, Esfahani A, et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. Aug 2009;52(8):1479-95. doi:10.1007/s00125-009-1395-7
  38. Gibb RD, McRorie JW, Jr., Russell DA, Hasselblad V, D'Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. Dec 2015;102(6):1604-14. doi:10.3945/ajcn.115.106989
  39. Akbari V, Hendijani F. Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutr Rev. Dec 2016;74(12):774-784. doi:10.1093/nutrit/nuw039
  40. Kasińska MA, Drzewoski J. Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol Arch Med Wewn. 2015;125(11):803-13. doi:10.20452/pamw.3156
  41. Samah S, Ramasamy K, Lim SM, Neoh CF. Probiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. Aug 2016;118:172-82. doi:10.1016/j.diabres.2016.06.014
  42. Yao K, Zeng L, He Q, Wang W, Lei J, Zou X. Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med Sci Monit. Jun 22 2017;23:3044-3053. doi:10.12659/msm.902600
  43. Zhang Q, Wu Y, Fei X. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Medicina (Kaunas). 2016;52(1):28-34. doi:10.1016/j.medici.2015.11.008

Keywords:
Supplements, blood sugar, integrative health 
Doc ID:
150604
Owned by:
Sara A. in Osher Center for Integrative Health
Created:
2025-05-12
Updated:
2026-03-09
Sites:
Osher Center for Integrative Health
Clean URL:
https://kb.wisc.edu/osher/supplements-to-lower-blood-sugar